A Post-Authorization Safety Study to Evaluate the Safety of Abrocitinib Exposure During Pregnancy in United States Healthcare Databases First published 04/04/2024 Last updated 19/04/2024 EU PAS number:EUPAS1000000096 Study Ongoing